GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Benchmark Holdings PLC (LSE:BMK) » Definitions » Sloan Ratio %

Benchmark Holdings (LSE:BMK) Sloan Ratio % : -7.33% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Benchmark Holdings Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Benchmark Holdings's Sloan Ratio for the quarter that ended in Dec. 2023 was -7.33%.

As of Dec. 2023, Benchmark Holdings has a Sloan Ratio of -7.33%, indicating the company is in the safe zone and there is no funny business with accruals.


Benchmark Holdings Sloan Ratio % Historical Data

The historical data trend for Benchmark Holdings's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benchmark Holdings Sloan Ratio % Chart

Benchmark Holdings Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.79 -12.11 0.91 -6.02 -8.04

Benchmark Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.04 -6.20 -6.29 -8.04 -7.33

Competitive Comparison of Benchmark Holdings's Sloan Ratio %

For the Drug Manufacturers - Specialty & Generic subindustry, Benchmark Holdings's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benchmark Holdings's Sloan Ratio % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Benchmark Holdings's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Benchmark Holdings's Sloan Ratio % falls into.



Benchmark Holdings Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Benchmark Holdings's Sloan Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Sloan Ratio=(Net Income (A: Sep. 2023 )-Cash Flow from Operations (A: Sep. 2023 )
-Cash Flow from Investing (A: Sep. 2023 ))/Total Assets (A: Sep. 2023 )
=(-23.146-20.005
--5.272)/471.295
=-8.04%

Benchmark Holdings's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(-29.49-6.364
--3.89)/436.165
=-7.33%

Benchmark Holdings's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was -2.858 (Mar. 2023 ) + -5.153 (Jun. 2023 ) + -13.852 (Sep. 2023 ) + -7.627 (Dec. 2023 ) = £-29.5 Mil.
Benchmark Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 1.422 (Mar. 2023 ) + 1.726 (Jun. 2023 ) + 8.789 (Sep. 2023 ) + -5.573 (Dec. 2023 ) = £6.4 Mil.
Benchmark Holdings's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -9.292 (Mar. 2023 ) + 0.179 (Jun. 2023 ) + 5.997 (Sep. 2023 ) + -0.774 (Dec. 2023 ) = £-3.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benchmark Holdings  (LSE:BMK) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Benchmark Holdings has a Sloan Ratio of -7.33%, indicating the company is in the safe zone and there is no funny business with accruals.


Benchmark Holdings Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Benchmark Holdings's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Benchmark Holdings (LSE:BMK) Business Description

Traded in Other Exchanges
Address
Yeoman Way, Highdown House, Worthing, West Sussex, GBR, BN99 3HH
Benchmark Holdings PLC is engaged in the healthcare sector. Its operating segment includes Genetics; Advanced Nutrition; Health; and Corporate. The company generates maximum revenue from the Advanced Nutrition segment. The Advanced Nutrition segment manufactures and provides technically advanced nutrition and health products to the aquaculture industry. Geographically, it derives a majority of its revenue from Norway and also has a presence in Vietnam; the Faroe Islands; Ecuador; India; Greece; Canada; Chile, and the Rest of World.

Benchmark Holdings (LSE:BMK) Headlines

No Headlines